How will the industry cope with Big Data?
Every
aspect of pharmaceutical research and development involves the
generation of vast quantities of data. The rapid transformation of this
raw data into useful knowledge brings a lot of advantages:
- ability to make 'data-driven' decisions
- better understanding and control of processes
- reduced costs and drug development time
- facilitating rapid post-approval changes
Given
this potential, the industry and regulators are eager to embed 'big
data' into their decision-making process. But concerns about data
integrity and parallel pressures to move to new manufacturing
technologies add to the challenge of embracing 'big data.'
Read this white paper and make your own decision if Big Data in Pharmaceuticals is a big opportunity or a challenge.
